SunilS.PatelMD

Ophthalmology • Abilene, TX

Retinal Disease

Physician

Join to view full profile

Dr. Patel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Patel's full profile

Already have an account?

Office
5441 Health Center Drive
Abilene, TX 79606
Phone+1 325-673-9806

Fax+1 325-673-9809
Is this information wrong?

Education & Training

University of Southern California/LAC+USC Medical CenterResidency, Ophthalmology, 1992 - 1995
Texas Health Resources (Dallas)Internship, Internal Medicine, 1991 - 1992
University of Texas Southwestern Medical SchoolClass of 1991

Certifications & Licensure

TX State Medical License 1997 - 2025
CA State Medical License 1993 - 2024
IL State Medical License 2010 - 2017
NJ State Medical License 2007 - 2017
NY State Medical License 1998 - 2017
OH State Medical License 2007 - 2012
American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

Fellow (FAAO) American Academy of Ophthalmology

Clinical Trials

Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy (N) Start of enrollment: 2010 Jun 01
Completed
Phase 2, Phase 3
Pilot Study of X-82 in Patients With Wet AMD Start of enrollment: 2012 Oct 01
Completed
Phase 1, Phase 2
Study of HUCNS-SC Subretinal Transplantation in Subjects With GA of AMD Start of enrollment: 2015 Jun 01
Terminated
Phase 2
Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 With or Without Lucentis™ in Patients With Wet AMD Start of enrollment: 2015 Jul 01
Completed
Phase 1
TLC399 (ProDex) in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO) Start of enrollment: 2017 Apr 01
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

1 citations
Biosimilar SB15 versus reference aflibercept in neovascular age-related macular degeneration: 1-year and switching results of a phase 3 clinical trial.
Woo, S., Sadda, S., Bradvica, M., Vajas, A., Sagong, M., Ernest, J., Studnička, J., Veith, M., Wylegala, E., Patel, S., Yun, C., Orski, M., Astakhov, S., Tóth-Molnár, ...> ;BMJ Open Ophthalmology. 2023 Dec 19
2 citations
Correction: Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial.
Sunil S Patel, David R Lally, Jason Hsu, Charles C Wykoff, David Eichenbaum, Jeffrey S Heier, Glenn J Jaffe, Keith Westby, Dhaval Desai, Liansheng Zhu, Arshad M Khanani> ;Eye. 2023 Dec 1
24 citations
Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial.
Sunil S Patel, David R Lally, Jason Hsu, Charles C Wykoff, David Eichenbaum, Jeffrey S Heier, Glenn J Jaffe, Keith Westby, Dhaval Desai, Liansheng Zhu, Arshad M Khanani> ;Eye. 2023 Dec 1
4 citations
Randomized Phase IIb Study of Brimonidine Drug Delivery System Generation 2 for Geographic Atrophy in Age-Related Macular Degeneration.
William R Freeman, Francesco Bandello, Eric Souied, Robyn H Guymer, Sunir J Garg, Fred K Chen, Ryan Rich, Frank G Holz, Sunil S Patel, Kimmie Kim, Francisco J López> ;Ophthalmology. Retina. 2023 Jul 1
2 citations
Impact of Modifying Abicipar Manufacturing Process in Patients with Neovascular Age-Related Macular Degeneration: MAPLE Study Results.
David Callanan, Rahul N Khurana, Raj K Maturi, Sunil Patel, Charles C Wykoff, David Eichenbaum, Arshad M Khanani, Tarek Hassan, Hanh Badger, Shraddha Mehta, Grace Le, ...> ;Clinical Ophthalmology. 2023 Jan 1
Reply.
Glenn J Jaffe, Keith Westby, Karl G Csaky, Jordi Monés, Joel A Pearlman, Sunil S Patel, Brian C Joondeph, John Randolph, Harvey Masonson, Kourous A Rezaei> ;Ophthalmology. 2021 Dec 1
5 citations
Phase 1 Dose-Escalation Study of Plasma Kallikrein Inhibitor THR-149 for the Treatment of Diabetic Macular Edema.
Pravin U Dugel, Arshad M Khanani, Brian B Berger, Sunil Patel, Mitchell Fineman, Glenn J Jaffe, Petra Kozma-Wiebe, Jeffrey Heier> ;Translational Vision Science & Technology. 2021 Dec 1
9 citations
Phase 1 Study of THR-687, a Novel, Highly Potent Integrin Antagonist for the Treatment of Diabetic Macular Edema.
Arshad M Khanani, Sunil S Patel, Victor H Gonzalez, Suk J Moon, Glenn J Jaffe, John A Wells, Petra Kozma, Pravin U Dugel, Raj K Maturi> ;Ophthalmology Science. 2021 Sep 1
Reply.
Glenn J Jaffe, Keith Westby, Karl G Csaky, Jordi Monés, Joel A Pearlman, Sunil S Patel, Brian C Joondeph, John Randolph, Harvey Masonson, Kourous A Rezaei> ;Ophthalmology. 2021 May 1
206 citations
C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Due to Age-Related Macular Degeneration: A Randomized Pivotal Phase 2/3 Trial.
Glenn J. Jaffe, Keith Westby, Karl G. Csaky, Jordi Monés, Joel A. Pearlman, Sunil S. Patel, Brian C. Joondeph, John Randolph, Harvey Masonson, K.A. Rezaei> ;Ophthalmology. 2021 Apr 1
31 citations
PHASE 2 STUDY OF THE SAFETY AND EFFICACY OF BRIMONIDINE DRUG DELIVERY SYSTEM (BRIMO DDS) GENERATION 1 IN PATIENTS WITH GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACU...
Baruch D. Kuppermann, Sunil S. Patel, David S. Boyer, Albert J. Augustin, William R. Freeman, Kevin Kerr, Qiang Guo, Susan Schneider, Francisco J. López> ;Retina. 2021 Jan 1
87 citations
Efficacy of Every Four Monthly and Quarterly Dosing of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration: The STAIRWAY Phase 2 Randomized Clinic...
Arshad M. Khanani, Sunil S. Patel, Philip J. Ferrone, Aaron Osborne, Jayashree Sahni, Susanna Grzeschik, Karen Basu, Jason S. Ehrlich, Zdenka Haskova, Pravin U. Dugel> ;JAMA Ophthalmology. 2020 Sep 1
56 citations
Safety and Efficacy of Different Doses and Regimens of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration: The AVENUE Phase 2 Randomized Clinical...
Jayashree Sahni, Pravin U. Dugel, Sunil S. Patel, Mark Chittum, Brian Berger, Marta del Valle Rubido, Shamil Sadikhov, Piotr Szczesny, Dietmar Schwab, Everson Nogoceke...> ;JAMA Ophthalmology. 2020 Sep 1
12 citations
Intravitreal Combined Aflibercept + Anti-Platelet-Derived Growth Factor Receptor β for Neovascular Age-Related Macular Degeneration: Results of the Phase 2 CAPELLA Trial.
Jeffrey S. Heier, Charles C. Wykoff, Nadia K Waheed, John W. Kitchens, Sunil S. Patel, Robert Vitti, Lorah Perlee, Karen W. Chu, Sergio Leal, Friedrich Asmus, Vladimir...> ;Ophthalmology. 2020 Feb 1
38 citations
Visual Function Decline Resulting from Geographic Atrophy Results from the Chroma and Spectri Phase 3 Trials
Jeffrey S. Heier, Dante J. Pieramici, Usha Chakravarthy, Sunil S Patel, Sunil Gupta, Andrew J. Lotery, Eleonora M. Lad, David Silverman, Erin C. Henry, Majid Anderesi,...> ;Ophthalmology. Retina. 2020 Jan 31
12 citations
Primary outcomes of the VIDI study: phase 2, double-masked, randomized, active-controlled study of ASP8232 for diabetic macular edema
Quan Dong Nguyen, Yasir J. Sepah, Brian B. Berger, David M. Brown, Diana V. Do, Alberto Garcia-Hernandez, Sunil S. Patel, Firas M. Rahhal, Yevgeniy Shildkrot, Ronny W....> ;International Journal of Retina and Vitreous. 2019 Aug 1
139 citations
Simultaneous Inhibition of Angiopoietin-2 and Vascular Endothelial Growth Factor-A with Faricimab in Diabetic Macular Edema: BOULEVARD Phase 2 Randomized Trial
Jayashree Sahni, Sunil S. Patel, Pravin U. Dugel, Arshad M. Khanani, Chirag Jhaveri, Charles C. Wykoff, Vrinda S. Hershberger, Meike Pauly-Evers, Shamil Sadikhov, Piot...> ;Ophthalmology. 2019 Aug 1
47 citations
Double-Masked, Randomized, Phase 2 Evaluation of Abicipar Pegol (an Anti-VEGF DARPin Therapeutic) in Neovascular Age-Related Macular Degeneration.
David Callanan, Derek Y Kunimoto, Raj K Maturi, Sunil S. Patel, Giovanni Staurenghi, Sebastian Wolf, Janet K. Cheetham, Hohman Thomas C, Kimmie Kim, Francisco J. López...> ;Journal of Ocular Pharmacology and Therapeutics. 2018 Dec 6
30 citations
Oral Tyrosine Kinase Inhibitor for Neovascular Age-Related Macular Degeneration: A Phase 1 Dose-Escalation Study
Timothy L Jackson, David S. Boyer, David M. Brown, Nauman A Chaudhry, Michael J. Elman, Chris Liang, Denis O'Shaughnessy, E. C. M. Parsons, Sunil S. Patel, Jason S. Sl...> ;JAMA Ophthalmology. 2017 Jul 1
73 citations
A multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edema.
David Callanan, Anat Loewenstein, Sunil S. Patel, Pascale Massin, Borja Corcóstegui, Xiao-yan Li, Jenny Jiao, Yehia Hashad, Scott M. Whitcup> ;Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie. 2017 Mar 1
78 citations
Enhanced Benefit in Diabetic Macular Edema from AKB-9778 Tie2 Activation Combined with Vascular Endothelial Growth Factor Suppression.
Peter A. Campochiaro, Arshad M. Khanani, Michael C. Singer, Sunil S. Patel, David S. Boyer, Pravin U. Dugel, Saleema Kherani, Barbara Withers, Laura Gambino, Kevin G. ...> ;Ophthalmology. 2016 Aug 1
16 citations
United States comparative costs and absenteeism of diabetic ophthalmic conditions.
Richard A. Brook, Nathan L. Kleinman, Sunil S. Patel, Jim E. Smeeding, Ian A Beren, Adam Turpcu> ;Postgraduate Medicine. 2015 Jun 3
608 citations
Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE.
David M. Brown, Quan Dong Nguyen, Dennis M. Marcus, David S. Boyer, Sunil S. Patel, Leonard Feiner, Patricio G. Schlottmann, Amy Chen Rundle, Jiameng Zhang, Roman G. R...> ;Ophthalmology. 2013 Oct 1
1153 citations
Ranibizumab for Diabetic Macular Edema: Results from 2 Phase III Randomized Trials: RISE and RIDE
Quan Dong Nguyen, David M. Brown, Dennis M. Marcus, David S. Boyer, Sunil S. Patel, Leonard Feiner, Andrea Gibson, Judy P. Sy, Amy Chen Rundle, J Jill Hopkins, Roman G...> ;Ophthalmology. 2012 Apr 1
263 citations
DEXAMETHASONE INTRAVITREAL IMPLANT FOR TREATMENT OF DIABETIC MACULAR EDEMA IN VITRECTOMIZED PATIENTS
David S. Boyer, David Faber, Sunil Gupta, Sunil S. Patel, Homayoun Tabandeh, Xiao-yan Li, Charlie C Liu, Jean Lou, Scott M. Whitcup> ;Retina. 2011 May 1
Join now to see all

Journal Articles

Efficacy of Every Four Monthly and Quarterly Dosing of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration
Arshad M Khanani, Sunil S Patel, Philip J Ferrone, Pravin U Dugel, JAMA Ophthalmology
Safety and Efficacy of Different Doses and Regimens of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration
Pravin U Dugel, Sunil S Patel, JAMA Ophthalmology

Authored Content

Efficacy of Every Four Monthly and Quarterly Dosing of Faricimab vs Ranibizumab in Neovascular Age-Related Macular DegenerationJuly 2020
Safety and Efficacy of Different Doses and Regimens of Faricimab vs Ranibizumab in Neovascular Age-Related Macular DegenerationJuly 2020
Efficacy of Every Four Monthly and Quarterly Dosing of Faricimab vs Ranibizumab in Neovascular Age-Related Macular DegenerationJuly 2020
Safety and Efficacy of Different Doses and Regimens of Faricimab vs Ranibizumab in Neovascular Age-Related Macular DegenerationJuly 2020
Safety and Efficacy of Different Doses and Regimens of Faricimab vs Ranibizumab in Neovascular Age-Related Macular DegenerationJuly 2020
Efficacy of Every Four Monthly and Quarterly Dosing of Faricimab vs Ranibizumab in Neovascular Age-Related Macular DegenerationJuly 2020
Join now to see all